Agios Pharmaceuticals AGIO
NASDAQ AGIO
$32.48 -0.77 (-2.32%)
At close: Oct 1, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Accumulated Depreciation (2012 - 2016)

Updated

Agios Pharmaceuticals' Accumulated Depreciation was $13.37 million in Q4 2016, up 74.5% from $7.66 million a year earlier.

Analysis

Agios Pharmaceuticals (AGIO) Accumulated Depreciation (2012 - 2016) Analysis & Trends

From Q4 2012 onward, Agios Pharmaceuticals has reported Accumulated Depreciation for 5 quarters.

  • Accumulated Depreciation has now increased for four consecutive years, with a four-year compound annual growth rate of 48.5% (FY2012 to FY2016).
  • In earlier years, Accumulated Depreciation was $7.66 million in FY2015 (+37.9%), $5.56 million in FY2014 (+32.6%), $4.19 million in FY2013 (+52.3%) and $2.75 million in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 13.37 Mn
Dec 31, 2015 7.66 Mn
Dec 31, 2014 5.56 Mn
Dec 31, 2013 4.19 Mn
Dec 31, 2012 2.75 Mn
API Access

Agios Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=AGIO&period=max&api_key=YOUR_API_KEY